Zelandia Life Science R&D Consulting ApS: Financial statements 2025
CVR: 40206051
Zelandia Life Science R&D Consulting ApS (CVR 40206051) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -72,481 and a net result of DKK -20,391 compared with DKK 670,851 the year before. Equity amounted to DKK 1,290,580. The solvency ratio was 98.7%. The company had 1 employee in the financial year.
- Gross Profit
- -72,481 kr.
- Profit/Loss
- -20,391 kr.
- Equity
- 1,290,580 kr.
- Total Assets
- 1,307,044 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -72 t. | -20 t. | 1.3 mio. | 1 |
| 2024 | - | 877 t. | 671 t. | 1.3 mio. | 1 |
| 2023 | - | 965 t. | 768 t. | 940 t. | - |
| 2022 | - | -78 t. | -92 t. | 172 t. | - |
| 2021 | - | 830 t. | 642 t. | 764 t. | - |
Find more companies like Zelandia Life Science R&D Consulting ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Zelandia Life Science R&D Consulting ApS has published its annual report for 2024. Gross profit came to DKK 876,542, and the net result was DKK 670,851.
About Zelandia Life Science R&D Consulting ApS
Zelandia Life Science R&D Consulting ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2019. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kristian Tage Hansen. The company is owned by KTHolding ApS. In 2025, the company reported a gross profit of DKK -72,481 and a net result of DKK -20,391 compared with DKK 670,851 the year before. Equity amounted to DKK 1,290,580.
